No Data
No Data
Leerink Partners Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $13
Benitec Biopharma Reports FY24 EPS ( $5.51) Vs ($14.12) in FY23
Benitec Biopharma | 10-K: FY2024 Annual Report
Express News | Benitec Biopharma Inc: Cash Runway Extended Through 2025
Express News | Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update
Press Release: Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update
No Data
No Data